CymaBay Therapeutics

+$0.10 (+3.58%) Today
+$0.02 (+0.69%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CBAY and other ETFs, options, and stocks.

About CBAY

CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products pipeline include Seladelpar, MBX-2982, CB-0406, and CB-001.

CEO
Sujal Shah
Employees
41
Headquarters
Newark, California
Founded
1988

CBAY Key Statistics

Market cap
244.69M
Price-Earnings ratio
—
Dividend yield
—
Average volume
636.67K
High today
$3.17
Low today
$2.89
Open price
$2.93
Volume
2.02M
52 Week high
$6.56
52 Week low
$2.76

CBAY News

Simply Wall StJan 22

Insider Buying: The CymaBay Therapeutics, Inc. Chief Medical Officer Just Bought US$61k Worth Of Shares

Even if it's not a huge purchase, we think it was good to see that Dennis Kim, the Chief Medical Officer of CymaBay Therapeutics, Inc. ( ) recently shelled out

CBAY Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 24, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure